Kenneth Hallock insider trades
Open-market stock purchases and sales by Kenneth Hallock, Director at Greenwich LifeSciences, Inc, from SEC Form 4 filings since Sep 29, 2020.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +162%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- GLSI Greenwich LifeSciences, Inc: 5 buys, last Dec 24, 2024